Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development

British Journal of Haematology

Volumn 130, Issue 1, 2005, Pages 92-95

  Sirianni, Maria Caterina ^a   Libi, Fabio ^a   Campagna, Massimo ^a   Rossi, Davide ^b   Capello, Daniela ^b   Sciaranghella, Gaia ^c   Carbone, Antonino ^d   Simonelli, Cecilia ^d   Monini, Paolo ^c   Gaidano, Gianluca ^b   Ensoli, Barbara ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Burkitt; Human herpesvirus type 8; Lymphoma; Major histocompatibility complex class I; Natural cytotoxicity

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PREDNISONE; VINCRISTINE;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA, VIRAL; DOWN-REGULATION; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; SEROLOGIC TESTS;

EID: 22144491214     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05581.x     Document Type: Article

References (12)

1. Brander, C., Suscovich, T., Lee, Y., Nguyen, P.T., O'Connor, P., Seebach, J., Jones, N.G., van Gorder, M., Walker, B.D. & Scadden, D.T. (2000) Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpesvirus. The Journal of Immunology, 165, 2077-2083.
2. Coscoy, L. & Ganem, D. (2000) Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proceedings of the National Academy of Sciences of the United States of America, 97, 8051-8056.
3. Coscoy, L. & Ganem, D. (2001) A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. The Journal of Clinical Investigation, 107, 1599-1606.
4. Gaidano, G., Contarini, M., Pastore, C., Saglio, G. & Matera, L. (1996) AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin. Proceedings of the Society for Experimental Biology and Medicine, 213, 196-205.
5. Horenstein, M.G., Nador, R.G., Chadburn, A., Hyejek, E.M., Inghirami, G., Knowles, D.M. & Ceserman, E. (1997) Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood, 90, 1186-1191.
6. Moretta, L., Bottino, C., Pende, D., Mingari, M.C., Biassoni, R. & Moretta, A. (2002) Human natural killer cells: their origin, receptors and function. European Journal of Immunology, 32, 1205-1211.
7. Rimessi, P., Bonaccorsi, A., Stürzl, M., Fabris, M., Brocca-Cofano, E., Caputo, A., Melucci-Vigo, G., Falchi, M., Cafaro, A., Cassai, E., Ensoli, B. & Monini, P. (2001) Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. Journal of Virology, 75, 7161-7174.
8. Simonelli, C., Tedeschi, R., Gloghini, A., Bortolin, M.T., Spina, M., Bidoli, E., Cinelli, R., De Paoli, P., Carbone, A. & Tirelli, U. (2005) Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy. Clinical Infectious Diseases, 40, 1022-1027.
9. Sirianni, M.C., Vincenzi, L., Topino, S., Giovannetti, A., Mazzetta, F., Libi, F., Scaramuzzi, D., Andreoni, M., Pinter, E., Baccarini, S., Rezza, G., Monini, P. & Ensoli, B. (2002) NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. European Journal of Immunology, 32, 2711-2720.
10. Suscovich, T.J., Paulose-Murphy, M., Harlow, J.D., Chen, Y., Thomas, S.Y., Mellott, T.J., Walker, B.D., Scadden, D.T., Zeichner, S. & Brander, C. (2004) Defective immune function of primary effusion lymphoma cells is associated with distinct KSHV gene expression profiles. Leukemia and Lymphoma, 45, 1223-1238.
11. Tierney, R.J., Steven, N., Young, L.S. & Rickinson, A.B. (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Journal of Virology, 68, 7374-7385.
12. Viejo-Borbolla, A. & Schulz, T.F. (2003) Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Review, 5, 222-229.